Difference between revisions of "Part:BBa K567011"
 
(5 intermediate revisions by 3 users not shown)
Line 2: Line 2:
 
<partinfo>BBa_K567011 short</partinfo>
 
<partinfo>BBa_K567011 short</partinfo>
  
−
aspartyl aminoacyl tRNA synthetase without anticodon recognition domain under the control of T7 promoter and lac operator. This biobrick is constructed by deleting the anticodon recognition domain of AspRS from E.coli. This modified AspRS can charge Asp to tRNA(Asp)-TAG (BBa_K567013) and tRNA(Asp)-AGG (BBa_K567012).  
+
aspartyl aminoacyl tRNA synthetase without anticodon recognition domain under the control of T7 promoter and ''lac'' operator. This biobrick is constructed by deleting the anticodon recognition domain of AspRS from ''E.coli''. This modified AspRS can charge Asp to tRNA<sup>Asp</sup>-TAG (BBa_K567013) and tRNA<sup>Asp</sup>-AGG (BBa_K567012).  
  
  
Line 9: Line 9:
 
[[image:11SJTU-ASPRS.jpg|600px|frame|center|''Fig 1.'' The design for modification is based on the crystal structure of ''E.coli'' AspRS coupled with tRNA (PDB ID: 1C0A). This figure shows ''E.coli'' aspartyl-tRNA synthetase with and without anticodon recognition domain. After this domain is depleted, the enzyme cannot bind tRNA<sup>Asp</sup> anticodon. Yet the ability of aminoacylation is maintained. ]]
 
[[image:11SJTU-ASPRS.jpg|600px|frame|center|''Fig 1.'' The design for modification is based on the crystal structure of ''E.coli'' AspRS coupled with tRNA (PDB ID: 1C0A). This figure shows ''E.coli'' aspartyl-tRNA synthetase with and without anticodon recognition domain. After this domain is depleted, the enzyme cannot bind tRNA<sup>Asp</sup> anticodon. Yet the ability of aminoacylation is maintained. ]]
  
−
We have used PT7-RFP-6AGG ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K567017 BBa_K567017]) as our Reporter. We have constructed tRNA<sup>Asp</sup>-AGG and PT7-TDRS (AspRS without anticodon recognition domain, )  ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K567012 BBa_K567012] and [https://parts.igem.org/wiki/index.php?title=Part:BBa_K567011 BBa_K567011])as the Modulator. tRNA<sup>Asp</sup>-AGG, which can recognize rare codon AGG, is under constitutive promoter. Our device works as follows: Without Modulator, RFP with 6 consecutive AGG insertions can hardly be expressed. When Modulator works, tRNA<sup>Asp</sup>-AGG can be charged with Asp by TDRS. tRNA<sup>Asp</sup>-AGG recognizes rare codon AGG on the Reporter RFP-6AGG. The ribosome gets through this part of the mRNA more easily. RFP is expressed. Red fluorescence is observed. Our experiment results are shown below.
 
  
−
[[image:11SJTU-ZBresult1.jpg|600px|frame|center|''Fig 2.'' With our Modulator ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K567012 BBa_K567012]  and [https://parts.igem.org/wiki/index.php?title=Part:BBa_K567011 BBa_K567011]), Reporter RFP-6AGG is expressed, demonstrating that our system works well. ]]
+
Related Biobrick:
  
−
[[image:11SJTU-ZBresult2.JPG|600px|frame|center|''Fig 3.'' aaRS Modulator + Reporter for Qualitative Analysis. aaRS Modulator + RFP-6AGG''(the middle three)'' emit red fluorescence. Wild type RFP ''(the first one from the left)'' exhibits bright red fluorescenceis. Control ''(first one from the right)'' exhibits no red fluoresence.]]
+
tRNA<sup>Asp</sup>-AGG  ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K567012 BBa_K567012])
  
−
Related Biobrick:
+
tRNA<sup>Asp</sup>-TAG  ([https://parts.igem.org/wiki/index.php?title=Part:BBa_K567013 BBa_K567013])
−
[https://parts.igem.org/wiki/index.php?title=Part:BBa_K567012 BBa_K567012]
+
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here

Latest revision as of 03:29, 29 October 2011

PT7-TDRS

aspartyl aminoacyl tRNA synthetase without anticodon recognition domain under the control of T7 promoter and lac operator. This biobrick is constructed by deleting the anticodon recognition domain of AspRS from E.coli. This modified AspRS can charge Asp to tRNAAsp-TAG (BBa_K567013) and tRNAAsp-AGG (BBa_K567012).


To deprive AspRS of its anticodon specificity, we analyzed the structure of AspRS and expressed a truncated AspRS without anticodon recognition domain. Our design is shown below. This modified enzyme keeps its ability of aminoacylation while loses its activity of recognizing anticodon of tRNA.

Fig 1. The design for modification is based on the crystal structure of E.coli AspRS coupled with tRNA (PDB ID: 1C0A). This figure shows E.coli aspartyl-tRNA synthetase with and without anticodon recognition domain. After this domain is depleted, the enzyme cannot bind tRNAAsp anticodon. Yet the ability of aminoacylation is maintained.


Related Biobrick:

tRNAAsp-AGG (BBa_K567012)

tRNAAsp-TAG (BBa_K567013)

Sequence and Features


Assembly Compatibility:
  • 10
    INCOMPATIBLE WITH RFC[10]
    Illegal EcoRI site found at 1595
    Illegal EcoRI site found at 1767
    Illegal XbaI site found at 48
    Illegal PstI site found at 1152
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal EcoRI site found at 1595
    Illegal EcoRI site found at 1767
    Illegal NheI site found at 1556
    Illegal PstI site found at 1152
    Illegal NotI site found at 1620
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal EcoRI site found at 1595
    Illegal EcoRI site found at 1767
    Illegal BamHI site found at 1589
    Illegal XhoI site found at 1629
  • 23
    INCOMPATIBLE WITH RFC[23]
    Illegal EcoRI site found at 1595
    Illegal EcoRI site found at 1767
    Illegal XbaI site found at 48
    Illegal PstI site found at 1152
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal EcoRI site found at 1595
    Illegal EcoRI site found at 1767
    Illegal XbaI site found at 48
    Illegal PstI site found at 1152
  • 1000
    COMPATIBLE WITH RFC[1000]